For the year ending 2025-12-31, VMD had -$4,039K decrease in cash & cash equivalents over the period. $11,931K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 15,376 |
| Depreciation and amortization | 28,613 |
| Stock-based compensation expense | 9,132 |
| Distributions of earnings received from equity method investments | 0 |
| Income from equity method investments | 0 |
| Loss (income) from debt investment | 0 |
| Loss (gain) on disposal of property and equipment | 2,239 |
| Amortization of deferred financing costs | 228 |
| Deferred income tax expense (benefit) | 3,109 |
| Accounts receivable, net | -1,158 |
| Inventory | -59 |
| Prepaid expenses and other assets | 503 |
| Trade payables | 479 |
| Deferred revenue | 359 |
| Accrued liabilities | 255 |
| Income tax payable/receivable | -4,110 |
| Net cash provided by operating activities | 51,916 |
| Purchase of property and equipment | 39,985 |
| Investment in equity investments | 0 |
| Cash paid for acquisitions, net of cash acquired | 26,332 |
| Proceeds from sale of debt security | 0 |
| Proceeds from sale of property and equipment | 16,151 |
| Net cash used in investing activities | -50,166 |
| Proceeds from exercise of options | 1,439 |
| Proceeds from term notes | 9,000 |
| Principal payments on term notes | 730 |
| Proceeds from revolving credit facilities | 13,000 |
| Principal payments on revolving credit facilities | 13,000 |
| Payments for debt issuance costs | 115 |
| Shares redeemed to pay income tax | 1,734 |
| Shares repurchased under the share repurchase program | 13,225 |
| Repayments of finance lease liabilities | 50 |
| Distributions to non-controlling interest | 374 |
| Net cash provided by (used in) financing activities | -5,789 |
| Net increase (decrease) in cash and cash equivalents | -4,039 |
| Cash and cash equivalents at beginning of year | 17,540 |
| Cash and cash equivalents at end of period | 13,501 |
VIEMED HEALTHCARE, INC. (VMD)
VIEMED HEALTHCARE, INC. (VMD)